{"id":4912,"date":"2019-10-09T19:01:25","date_gmt":"2019-10-09T17:01:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/"},"modified":"2019-10-09T19:01:25","modified_gmt":"2019-10-09T17:01:25","slug":"global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/","title":{"rendered":"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4846792\/global-respiratory-diseases-adenovirus?utm_source=BW&#038;utm_medium=PressRelease&#038;utm_code=cw3s3h&#038;utm_campaign=1306609+-+Global+Respiratory+Diseases+2019+Including%3A+Adenovirus%2C+Influenza%2C+Legionella%2C+Mononucleosis%2C+Mycoplasma%2C+Pneumonia%2C+RSV%2C+Tuberculosis&#038;utm_exec=anwr281prd\" shape=\"rect\" rel=\"noopener noreferrer\">&#8220;Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/5\/ResearchAndMarkets_800px.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/21\/ResearchAndMarkets_800px.jpg\"><\/a><\/p>\n<p>\n<strong>About this Report <\/strong>\n<\/p>\n<p>\nThis new 366-page report from the author presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.\n<\/p>\n<p>\n<strong>The report provides test volume and sales forecasts by country and market segment, including:<\/strong>\n<\/p>\n<ul>\n<li>\nHospitals\n<\/li>\n<li>\nCommercial\/Private Labs\n<\/li>\n<li>\nPhysician Offices\n<\/li>\n<li>\nPublic Health Labs\n<\/li>\n<\/ul>\n<p>\nIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country.\n<\/p>\n<p>\n<strong>Also, the report:<\/strong>\n<\/p>\n<ul>\n<li>\nExamines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging Technologies; thirteen\n<\/li>\n<li>\nReviews features and operating characteristics of major analyzers used for respiratory disease testing;\n<\/li>\n<li>\nProfiles key suppliers and potential market entrants developing innovative Technologies and products; and\n<\/li>\n<li>\nAnalyzes emerging opportunities, alternative market penetration strategies, market entry barriers\/risks, and strategic planning issues.\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned <\/strong>\n<\/p>\n<ul>\n<li>\nAbbott\n<\/li>\n<li>\nAffymetrix\n<\/li>\n<li>\nBeckman Coulter\/Danaher\n<\/li>\n<li>\nBecton Dickinson\n<\/li>\n<li>\nbioMerieux\n<\/li>\n<li>\nBio-Rad\n<\/li>\n<li>\nCepheid\n<\/li>\n<li>\nDiamedix\n<\/li>\n<li>\nDiaSorin\n<\/li>\n<li>\nEiken Chemical\n<\/li>\n<li>\nElitech Group\n<\/li>\n<li>\nEnzo Biochem\n<\/li>\n<li>\nFujirebio\n<\/li>\n<li>\nGrifols\n<\/li>\n<li>\nHologic\/Gen-Probe\n<\/li>\n<li>\nID Biomedical\/GSK\n<\/li>\n<li>\nKreatech\/Leica\n<\/li>\n<li>\nLonza\n<\/li>\n<li>\nOrtho-Clinical Diagnostics\n<\/li>\n<li>\nQiagen\n<\/li>\n<li>\nRoche\n<\/li>\n<li>\nScienion\n<\/li>\n<li>\nSequenom\n<\/li>\n<li>\nSeraCare\n<\/li>\n<li>\nSiemens\n<\/li>\n<li>\nTakara Bio\n<\/li>\n<li>\nThermo Fisher\/Life Technology\n<\/li>\n<li>\nWallac\/PE\n<\/li>\n<li>\nWako\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4846792\/global-respiratory-diseases-adenovirus?utm_source=BW&#038;utm_medium=PressRelease&#038;utm_code=cw3s3h&#038;utm_campaign=1306609+-+Global+Respiratory+Diseases+2019+Including%3A+Adenovirus%2C+Influenza%2C+Legionella%2C+Mononucleosis%2C+Mycoplasma%2C+Pneumonia%2C+RSV%2C+Tuberculosis&#038;utm_exec=anwr281prd\" shape=\"rect\" rel=\"noopener noreferrer\">https:\/\/www.researchandmarkets.com\/r\/um0mk0<\/a>\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&#038;sty=20191009005627r1&#038;sid=web02&#038;distro=nx&#038;lang=en\" style=\"width:0;height:0\"><span class=\"bwct31415\"><\/span><\/p>\n<p><b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;&#x3a;&#x70;r&#x65;&#115;&#x73;&#64;&#x72;&#101;s&#x65;&#97;&#x72;&#99;&#x68;&#97;n&#x64;&#109;&#x61;&#114;&#x6b;&#101;t&#x73;&#46;&#x63;&#111;&#x6d;\" shape=\"rect\" rel=\"noopener noreferrer\">&#112;&#x72;&#101;&#x73;&#115;&#x40;r&#x65;s&#x65;a&#114;&#x63;&#104;&#x61;&#110;&#x64;&#109;&#x61;r&#x6b;e&#x74;s&#46;&#x63;&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. About this Report This new 366-page report from the author presents detailed analysis of the Respiratory Disease market in the US, Europe &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-4912","6":"format-standard","7":"category-allgemein"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. About this Report This new 366-page report from the author presents detailed analysis of the Respiratory Disease market in the US, Europe ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-09T17:01:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/21\/ResearchAndMarkets_800px.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2019-10-09T17:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/\"},\"wordCount\":310,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005627\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\",\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/\",\"name\":\"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005627\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\",\"datePublished\":\"2019-10-09T17:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005627\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005627\\\/en\\\/371054\\\/21\\\/ResearchAndMarkets_800px.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. About this Report This new 366-page report from the author presents detailed analysis of the Respiratory Disease market in the US, Europe ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2019-10-09T17:01:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis &#8211; ResearchAndMarkets.com","datePublished":"2019-10-09T17:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/"},"wordCount":310,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","articleSection":["Allgemein"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/","name":"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","datePublished":"2019-10-09T17:01:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/21\/ResearchAndMarkets_800px.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20191009005627\/en\/371054\/21\/ResearchAndMarkets_800px.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-respiratory-diseases-2019-including-adenovirus-influenza-legionella-mononucleosis-mycoplasma-pneumonia-rsv-tuberculosis-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/4912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=4912"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/4912\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=4912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=4912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=4912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}